Cargando…

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life

Detalles Bibliográficos
Autores principales:	Robinson, Jennifer G., Williams, Kevin Jon, Gidding, Samuel, Borén, Jan, Tabas, Ira, Fisher, Edward A., Packard, Chris, Pencina, Michael, Fayad, Zahi A., Mani, Venkatesh, Rye, Kerry Anne, Nordestgaard, Børge G., Tybjærg‐Hansen, Anne, Douglas, Pamela S., Nicholls, Stephen J., Pagidipati, Neha, Sniderman, Allan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474943/ https://www.ncbi.nlm.nih.gov/pubmed/30371276 http://dx.doi.org/10.1161/JAHA.118.009778

Ejemplares similares

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
por: Sniderman, Allan D., et al.
Publicado: (2018)

Data on plasma levels of apolipoprotein E, correlations with lipids and lipoproteins stratified by APOE genotype, and risk of ischemic heart disease
por: Rasmussen, Katrine L., et al.
Publicado: (2016)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort
por: Rasmussen, Katrine L, et al.
Publicado: (2019)

Role of High‐Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control
por: Manandhar, Bikash, et al.
Publicado: (2019)

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
por: Titanji, Boghuma, et al.
Publicado: (2020)

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
por: Khera, Rohan, et al.
Publicado: (2020)

Impact of Reperfusion on Temporal Immune Cell Dynamics After Myocardial Infarction
por: Zhang, Richard Ying Ke, et al.
Publicado: (2023)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
por: Wilkinson, Michael J., et al.
Publicado: (2023)

Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
por: Nordestgaard, Liv Tybjærg, et al.
Publicado: (2022)

Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals
por: Nordestgaard, Liv Tybjærg, et al.
Publicado: (2018)

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
por: Doi, Takahito, et al.
Publicado: (2023)

Genetic variants in the adenosine triphosphate-binding cassette transporter A1 and risk of age-related macular degeneration
por: Nordestgaard, Liv Tybjærg, et al.
Publicado: (2023)

Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study
por: Dahl, Morten, et al.
Publicado: (2005)

A Population-based Study of Morbidity and Mortality in Mannose-binding Lectin Deficiency
por: Dahl, Morten, et al.
Publicado: (2004)

New methods to image unstable atherosclerotic plaques
por: Andrews, Jack P.M., et al.
Publicado: (2018)

Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life
por: Taageby Nielsen, Sofie, et al.
Publicado: (2023)

Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group
por: Gooding, Holly C., et al.
Publicado: (2020)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
por: Benn, Marianne, et al.
Publicado: (2017)

Fostering compassion and reducing burnout: How can health system leaders respond in the Covid-19 pandemic and beyond?
por: Hofmeyer, Anne, et al.
Publicado: (2020)

Knowledge for nurses to better care for themselves so they can better care for others during the Covid-19 pandemic and beyond
por: Hofmeyer, Anne, et al.
Publicado: (2020)

Adherence to the NASPE Guideline for Amiodarone Monitoring at a Medical University
por: Bickford, Courtney L., et al.
Publicado: (2006)

Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population
por: Ørsted, David Dynnes, et al.
Publicado: (2007)

Population-Based Resequencing of APOA1 in 10,330 Individuals: Spectrum of Genetic Variation, Phenotype, and Comparison with Extreme Phenotype Approach
por: Haase, Christiane L., et al.
Publicado: (2012)

ABCA7 and risk of dementia and vascular disease in the Danish population
por: Kjeldsen, Emilie W., et al.
Publicado: (2017)

APOE and dementia – resequencing and genotyping in 105,597 individuals
por: Rasmussen, Katrine L., et al.
Publicado: (2020)

Assessment of Patient Satisfaction With Telephone and Mail Interventions Provided by a Clinical Pharmacy Cardiac Risk Reduction Service
por: Holsclaw, Susan L., et al.
Publicado: (2005)

The Earlier Methods Employed in the Treatment of Syphilis
por: Packard, Francis R.
Publicado: (1923)

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
por: Ginsberg, Henry N, et al.
Publicado: (2021)

Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease Activity: Coronary and Carotid Applications
por: Daghem, Marwa, et al.
Publicado: (2020)

Atherosclerotic Renal Artery Stenosis: Should we Intervene Earlier?
por: de Leeuw, Peter W., et al.
Publicado: (2018)

ABC Transporter Genes and Risk of Type 2 Diabetes: A study of 40,000 individuals from the general population
por: Schou, Jesper, et al.
Publicado: (2012)

Blood Leukocyte Counts in Alzheimer Disease
por: Luo, Jiao, et al.
Publicado: (2022)

Deficiency of AXL in Bone Marrow-Derived Cells Does Not Affect Advanced Atherosclerotic Lesion Progression
por: Subramanian, Manikandan, et al.
Publicado: (2016)

Apolipoprotein B in cardiovascular risk assessment
por: Ahmad, Maud, et al.
Publicado: (2023)

Blood–brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals
por: Juul Rasmussen, Ida, et al.
Publicado: (2019)

Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention
por: Juul Rasmussen, Ida, et al.
Publicado: (2020)

Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study
por: Christoffersen, Mette, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s7t0gb0s4hoqtnurumfrcvu5l8